CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-14 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −9,851 | $30.60 | $301K | 1,172,744 |
| 2021-01-14 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −5,149 | $31.10 | $160K | 1,167,595 |
| 2020-12-17 | Bhavnagri Veer General Counsel | Option exercise | +51,500 | $2.27 | $117K | 405,402 |
| 2020-12-17 | Bhavnagri Veer General Counsel | Option exercise · Stock Option (Right to Buy) | −51,500 | 162,300 | ||
| 2020-11-16 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −4,634 | $32.60 | $151K | 1,192,961 |
| 2020-11-16 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −10,366 | $33.00 | $342K | 1,182,595 |
| 2020-10-15 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −5,104 | $39.47 | $201K | 1,207,491 |
| 2020-10-15 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −4,218 | $40.07 | $169K | 1,203,273 |
| 2020-10-15 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −3,479 | $41.33 | $144K | 1,199,794 |
| 2020-10-15 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −2,099 | $42.32 | $89K | 1,197,695 |
| 2020-10-15 | SCHMIDT ERIC THOMAS Chief Financial Officer | Sale | −100 | $43.01 | $4K | 1,197,595 |
| 2020-10-13 | MOORE ALISON Chief Technical Officer | Option exercise | +11,031 | $2.27 | $25K | 119,401 |
| 2020-10-13 | MOORE ALISON Chief Technical Officer | Sale | −11,031 | $42.00 | $463K | 108,370 |
| 2020-10-13 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −11,031 | 579,959 | ||
| 2020-10-12 | MOORE ALISON Chief Technical Officer | Option exercise | +24,233 | $2.27 | $55K | 132,603 |
| 2020-10-12 | MOORE ALISON Chief Technical Officer | Sale | −24,233 | $42.00 | $1.0M | 108,370 |
| 2020-10-12 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −24,233 | 590,990 | ||
| 2020-10-09 | MOORE ALISON Chief Technical Officer | Option exercise | +30,199 | $2.27 | $69K | 147,879 |
| 2020-10-09 | MOORE ALISON Chief Technical Officer | Sale | −39,509 | $41.00 | $1.6M | 108,370 |
| 2020-10-09 | MOORE ALISON Chief Technical Officer | Option exercise · Stock Option (Right to Buy) | −30,199 | 615,223 |
Page 14 of 18 · 348 trades